ClinicalTrials.Veeva

Menu

Dexpanthenol Mouthwash to Treat Oral Mucositis

S

Shahid Beheshti University of Medical Sciences

Status and phase

Unknown
Phase 2

Conditions

Oral Mucositis (Ulcerative) Due to Radiation

Treatments

Drug: Dexpanthenol

Study type

Interventional

Funder types

Other

Identifiers

NCT01318889
BMU1360

Details and patient eligibility

About

Oral mucositis can be a significant problem for cancer patients. It is typically associated with pain and increased risk of infection and can lead to impaired nutritional status and inadequate hydration.it can be seen in the patient population receiving high-dose head and neck radiation therapy (85%-100%). Topical dexpanthenol acts like a moisturizer, improving stratum corneum hydration, reducing transepidermal water loss and maintaining skin softness and elasticity. The stimulation of epithelization, granulation and mitigation of itching were the most prominent effects of formulations containing dexpanthenol. The investigators suppose that dexpanthenol mouth wash may improve oral mucositis.

Full description

Patients will be given a bottle of 5% Dexpanthenol mouthwash and they are asked to rinse 10 ml of it three times a day. At the onset of mucositis and then for 4 subsequent weeks they will be examined to evaluate the condition of their oral mucosa.By the advent of mucositis stage 4 ,at any time during the 4 weeks of study,the patient would be out.if any patient shows allergic reaction to dexpanthenol,he/she would be out of study too.

Enrollment

30 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. without any systemic disease
  2. estimated survival of at least 6 months
  3. without any mental disorders
  4. grade 1 to 3 WHO mucositis

Exclusion criteria

  1. development of grade 4 WHO mucositis
  2. Brachytherapy
  3. allergy to the drug
  4. dissatisfaction of the patient

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 1 patient group

normal saline
Experimental group
Description:
mouth wash of normal saline ,three times a day, 10 cc each time
Treatment:
Drug: Dexpanthenol

Trial contacts and locations

1

Loading...

Central trial contact

Jamileh beigom Taheri, professor; Fahimeh Anbari, resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems